| 000 | 01558 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516112833.0 | ||
| 264 | 0 | _c20130213 | |
| 008 | 201302s 0 0 eng d | ||
| 022 | _a2219-2840 | ||
| 024 | 7 |
_a10.3748/wjg.v18.i35.4944 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSun, Chen | |
| 245 | 0 | 0 |
_aDoes gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer? _h[electronic resource] |
| 260 |
_bWorld journal of gastroenterology _cSep 2012 |
||
| 300 |
_a4944-58 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aAnsari, Daniel | |
| 700 | 1 | _aAndersson, Roland | |
| 700 | 1 | _aWu, De-Quan | |
| 773 | 0 |
_tWorld journal of gastroenterology _gvol. 18 _gno. 35 _gp. 4944-58 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3748/wjg.v18.i35.4944 _zAvailable from publisher's website |
| 999 |
_c22127282 _d22127282 |
||